ASMI's Board of Directors

 

ASMI's Board of Directors 2018-19

Chairperson

Lindsay Forrest
Consultant

 

 

Lindsay Forrest pic

 

 

 

Board Members 2018-19

Theresa Agnew
Area General Manager, Australia and New Zealand
GSK Consumer Healthcare

Theresa Agnew

 

 Robert Barnes
 Head of Consumer OTC Division
 Aspen Pharmacare Australia

 

 

 Robert Barnes

Jonathan Biddle
VP Asia/Pacific Prestige Consumer Healthcare & General Manager
Care Pharmaceuticals

Jon Biddle

Glenn Cochran
Regional Director ANZ - Health
RB

Glenn ASMI new

Andrew Jenkin
General Manager, Australia & New Zealand
Pfizer PFE Australia Pty Ltd

Andrew Jenkin

James Jones
Managing Director
Takeda

James Jones

 

Alan Oppenheim
Managing Director
Ego Pharmaceuticals

 

 

Alan Oppenheim

Mark Sargent
General Manager, Australia & New Zealand
Bayer Healthcare Consumer Care

Mark Sargent

Seona Wallace  
Managing Director
HealthOne

Seona

ASMI Board of Directors Elections

As a company limited by guarantee, ASMI is governed by a constitution and a Board of Directors with the following attributes:
  • Up to 6 Official Delegates elected by ASMI ordinary members
  • Up to 4 skills based directors appointed by the board and may include up to 2 honorary life members and associate members